A significant advance in cancer study is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This vital tumor suppressor protein is frequently disabled in many forms of malignancies, resulting https://esocialmall.com/story7463285/mini-antibodies-reactivate-the-p53-protein-a-potential-hope-for-tumor-management